The cost of drugs is a top concern for policymakers and the public. The urgency of this issue has resulted in a rapidly changing landscape. In the past year, we’ve seen new federal legislation focused on drug pricing, payment innovations by insurers, and disruptions in the consumer market from the private sector. But what will the effects of these changes be? Join Penn LDI as we host a one-day conference to address new and pending policy changes, public and private sector innovations in this complicated market, and what the future holds for drug pricing.